Liver fibrosis attributed to lipid lowering medications: Two cases

Journal of Internal Medicine

Volumn 250, Issue 3, 2001, Pages 249-254

  Punthakee, Z ^a   Scully, L J ^a   Guindi, M M ^a   Ooi, T C ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Adverse effects; Anticholesteremic agents; Fibric acid derivatives; Fibrosis; HMG CoA reductase inhibitors; Liver diseases

Indexed keywords

ANTILIPEMIC AGENT; COLESTYRAMINE; FENOFIBRATE; GEMFIBROZIL; LIVER ENZYME; MEVINOLIN; PARACETAMOL; PRAVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; CASE REPORT; CHRONIC ACTIVE HEPATITIS; CLINICAL FEATURE; DISEASE COURSE; DRUG MONITORING; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LONG TERM CARE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTICHOLESTEREMIC AGENTS; BIOPSY, NEEDLE; FEMALE; HEPATITIS, CHRONIC; HEPATITIS, TOXIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035720401     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00848.x     Document Type: Article

References (19)

1. Current perspectives on statins
2. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
3. Drug interactions and side effect of hypolipidemic drugs
4. Hydrophilicity/lipophilicity: Relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors
5. Criteria of drug-induced liver disorders. Report of an international concensus meeting
6. Acute cholestatic hepatitis during simvastatin administration
7. Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors
8. Un cas d'hepatite a la simvastatine
9. Hepatite a la simvastatine
10. Acute cholestatic hepatitis associated with pravastatin
11. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin
12. Hepatitis inducida por lovastatina
13. Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin
14. Lovastatin-induzierte akute cholestatische hepatitis
15. Hepatite aigue severe cirrhogene apres prise de ciprofibrate
16. Hepatite chronique active associee a des anticorps anti-noyau induite par le fenofibrate
17. Hepatite chronique active cirrhogene au fenofibrate
18. Hepatites d'allure auto-immune induites par les fibrates
19. Methotrexate and histologic hepatic abnormalities: A meta-analysis